Clinical Trials Directory

Trials / Completed

CompletedNCT03580252

Reliability of Hammersmith Examination in Prediction of Neurological Outcomes (REHAPENO)

Reliability of Hammersmith Examination in Prediction of Neurological Outcomes In Preterm Infants - Observational Study (REHAPENO)

Status
Completed
Phase
Study type
Observational
Enrollment
50 (actual)
Sponsor
Abha International Private Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

In this study workers are trying to test the correlation between Hammersmith Infant Neurological Examination and MRI brain/cranial ultrasound with early prediction of neurological developmental outcome of preterm neonates. This study is prospective cross-sectional collecting the data of patients according to daily standard medical practice

Detailed description

The primary aim of this study is to evaluate the neurobehavioural performance of infants born preterm using the Hammersmith Infant Neurological Examination (HINE) in standard medical practice and compare it with the gold standard MRI and ultrasound imagings. It would be possible to check do we need to use all the 3 examinations or Hammersmith examination would be enough reliable predictor. Secondary aim is to explore the relationships between MRI brain /cranial us abnormalities and HINE at term-equivalent age in infants born preterm in prediction of neurological outcome at 1 year of chronological age. This study will be only single arm/single group. This group would receive the regular practice of MRI, Ultrasound (US) and Hammersmith assessments. The 3 assessments would be compared in relationships with the neonatal developmental outcomes (developmental milestones).

Conditions

Interventions

TypeNameDescription
OTHERCorrelation analyses for the outcomesNo medical intervention would be done. The single arm would receive regular practice of Hammersmith Assessment and MRI / Ultrasound

Timeline

Start date
2018-03-01
Primary completion
2019-01-25
Completion
2019-01-25
First posted
2018-07-09
Last updated
2019-01-28

Locations

1 site across 1 country: Saudi Arabia

Source: ClinicalTrials.gov record NCT03580252. Inclusion in this directory is not an endorsement.